Brian Gibler / Friday, December 4, 2020 / Categories: Fibrinolytic Therapy, Care Team, EM, Hosp Med, Neuro, Neurophys, Neurosurg, Stroke Team, Diagnosis, ICH, IS, SAH, Topics, Controversies, EBM, IV Rx, Physiology, Standard Care, Treatments, Types of Content, Podcast, ICU & Critical Care, Care Team, Critical Care, Hosp Med, Neuro, Stroke Team, Types of Content, Podcast, Podcast What Pitfalls Do Clinicians Face In Understanding Statistics In Acute Stroke Trials? Moderator: Jordan Bonomo, MD, FCCM, FNCS Other Participants: Uwe Stolz, PhD, MPH Statistics can illuminate or obfuscate. Clinicians need to understand acute stroke trial data and statistics in meaningful ways, but challenges abound. In this lively discussion of statistical pitfalls, Dr. Uwe Stolz shares his deep expertise in data analytics with listeners to help them understand the pitfalls in stroke trial statistics. Imagine a podcast about statistics that was enjoyable and informative – this is it! Previous Article How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients? Next Article How Do I Identify Patients at Risk for a Secondary Event Following an Initial Acute Ischemic Stroke? Print 11089 Rate this article: No rating 1 comments on article "What Pitfalls Do Clinicians Face In Understanding Statistics In Acute Stroke Trials?" Ken Milne Dr. Stolz did a good job of discussing some of the statistical challenges in understanding stroke trial data. He mentioned a recent large stroke trial that had some issues. Was he referring to ECASS-3 and Alper et al reanalysis of this trial? 12/17/2021 8:33 AM Please login or register to post comments.
Ken Milne Dr. Stolz did a good job of discussing some of the statistical challenges in understanding stroke trial data. He mentioned a recent large stroke trial that had some issues. Was he referring to ECASS-3 and Alper et al reanalysis of this trial? 12/17/2021 8:33 AM